P/E - CK Life Sciences Intl (Holdings) Inc (HKEX:775) - Alpha Spread

CK Life Sciences Intl (Holdings) Inc
HKEX:775

Watchlist Manager
CK Life Sciences Intl (Holdings) Inc Logo
CK Life Sciences Intl (Holdings) Inc
HKEX:775
Watchlist
Price: 0.36 HKD 1.41% Market Closed
Market Cap: 3.5B HKD
Have any thoughts about
CK Life Sciences Intl (Holdings) Inc?
Write Note

P/E
Price to Earnings

-185.4
Current
54.9
Median
23.7
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-185.4
=
Market Cap
3.5B HKD
/
Net Income
-18.7m HKD
All Countries
Close
Earnings Growth
HK
CK Life Sciences Intl (Holdings) Inc
HKEX:775
Average P/E: 57.5
Negative Multiple: -185.4
N/A
US
Abbvie Inc
NYSE:ABBV
64.5
406%
US
Amgen Inc
NASDAQ:AMGN
57.9
74%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
29.4
56%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -244.9
38%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -505.7 N/A
US
Gilead Sciences Inc
NASDAQ:GILD
99.3
71%
AU
CSL Ltd
ASX:CSL
36.6
64%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.5 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 169.6 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -481 N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
N/A
2-Years Forward
P/E
N/A
3-Years Forward
P/E
N/A

See Also

Discover More